Related Experiment Video
Updated: Oct 26, 2025
09:31
Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
7.4K
Strategies for durable β cell replacement in type 1 diabetes
Todd M Brusko1,2, Holger A Russ3, Cherie L Stabler4
1Department of Pathology, Immunology and Laboratory Medicine, and Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
Science (New York, N.Y.)
|July 30, 2021
Summary
New stem cell therapies and immunomodulatory treatments aim to restore natural glucose regulation for type 1 diabetes patients, offering a path beyond current monitoring and insulin delivery. These advances target durable beta cell replacement and preventing immune rejection.
Area of Science:
- Endocrinology and Metabolism
- Regenerative Medicine
- Immunology
Background:
- Current blood glucose monitoring and insulin therapies improve quality of life for type 1 diabetes (T1D) patients but do not fully replicate native islet function.
- Restoring endogenous glucose regulation remains a key challenge in T1D management.
Purpose of the Study:
- To examine integrated advancements in islet cell replacement and immunomodulatory therapies for T1D.
- To highlight innovative approaches for restoring beta cell function and preventing immune-mediated destruction.
Main Methods:
- Review of recent progress in stem cell biology for generating insulin-producing cells.
- Analysis of novel graft site designs for improved cell engraftment and function.
- Exploration of cutting-edge immunomodulatory strategies to prevent allograft rejection and autoimmune recurrence.
Main Results:
- Advances in stem cell sources and biomaterials offer new avenues for beta cell replacement.
- Improved engraftment strategies enhance the potential for functional islet cell grafts.
- Emerging immunomodulatory approaches show promise in overcoming barriers to long-term graft survival.
Conclusions:
- Integrated strategies combining stem cell-derived islets and advanced immunomodulation are crucial for durable T1D treatment.
- A deeper understanding of T1D etiology, beta cell biology, and biomaterial science is driving therapeutic innovation.
- These advancements offer significant potential to durably replace destroyed beta cells and restore metabolic control in type 1 diabetes.
Related Concept Videos
01:23Tissue Renewal without Stem Cells
1.9K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.9K
01:25Insulin: Biosynthesis, Chemistry, and Preparation
700
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
700
01:36Carbohydrate Metabolism
12.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.7K
01:15Diabetes: Management and Pharmacotherapy
595
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
595
01:22Diabetes Mellitus: Overview and Type I Subtype
4.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.0K
01:16Insulin: Dosing Regimen and Adverse Effects
329
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
329